基本信息
浏览量:1
职业迁徙
个人简介
My long-term research interests involve the development of a comprehensive understanding of key molecular pathways involved in cancer immune modulation and the identification of new immune modulator-targeted therapies in brain tumor treatment.
Immune evasion represents one pivotal pathogenesis contributing to cancer progression. Understanding the mechanisms underlying the co-evolution of cancer cells and host immune system in a spatiotemporal manner is fundamental for the early diagnosis, effective treatment, and prognostic evaluation for all cancer diseases. As an immunologist and biochemist with clinical medicine background, I am interested in unraveling the immune regulatory mechanisms involved in different brain tumors, such as the glioblastoma multiforme (GBM), a highly aggressive malignancy with a dismal average survival of 14.6 months. The special brain anatomy and lymphatic system provide a unique angle to study organ-specific cancer immunology. By utilization of various molecular/cellular immunological techniques in combination with high-throughput analysis platforms, such as single cell RNASeq, tissue microarray, high-dimensional time-of-flight mass cytometry (CyTOF), my research interests aim to answer key questions in following categories: 1) identification of novel therapeutic and prognostic biomarkers using patient specimens from GBM clinical trials; 2) establishment of novel animal GBM models that closely resemble the immunopathological and molecular patterns of human GBM undergone different treatment modalities; 3) investigation of the interactions between GBM infiltrating immune cells, tumor angiogenesis, hypoxia and tumor necrosis; 4) comparative studies of tumor immune responses between GBM and other peripheral tumors, such as melanoma and pancreatic cancer, to elucidate the distinct immunoregulatory pathways in central nervous system tumors. My ultimate goal is to discover reliable GBM diagnostic/prognostic biomarkers and develop novel effective immunotherapeutic approaches that can be applied with other treatments to conquer the devastating GBM.
Immune evasion represents one pivotal pathogenesis contributing to cancer progression. Understanding the mechanisms underlying the co-evolution of cancer cells and host immune system in a spatiotemporal manner is fundamental for the early diagnosis, effective treatment, and prognostic evaluation for all cancer diseases. As an immunologist and biochemist with clinical medicine background, I am interested in unraveling the immune regulatory mechanisms involved in different brain tumors, such as the glioblastoma multiforme (GBM), a highly aggressive malignancy with a dismal average survival of 14.6 months. The special brain anatomy and lymphatic system provide a unique angle to study organ-specific cancer immunology. By utilization of various molecular/cellular immunological techniques in combination with high-throughput analysis platforms, such as single cell RNASeq, tissue microarray, high-dimensional time-of-flight mass cytometry (CyTOF), my research interests aim to answer key questions in following categories: 1) identification of novel therapeutic and prognostic biomarkers using patient specimens from GBM clinical trials; 2) establishment of novel animal GBM models that closely resemble the immunopathological and molecular patterns of human GBM undergone different treatment modalities; 3) investigation of the interactions between GBM infiltrating immune cells, tumor angiogenesis, hypoxia and tumor necrosis; 4) comparative studies of tumor immune responses between GBM and other peripheral tumors, such as melanoma and pancreatic cancer, to elucidate the distinct immunoregulatory pathways in central nervous system tumors. My ultimate goal is to discover reliable GBM diagnostic/prognostic biomarkers and develop novel effective immunotherapeutic approaches that can be applied with other treatments to conquer the devastating GBM.
研究兴趣
论文共 96 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Brain, Behavior, & Immunity - Health (2024): 100753-100753
Neuro-oncologyno. Supplement_5 (2023): v147-v148
引用0浏览0引用
0
0
FRONTIERS IN IMMUNOLOGY (2023): 1122299-1122299
crossref(2023)
Neuro-oncologyno. Supplement_5 (2023): v47-v47
引用0浏览0引用
0
0
Journal for immunotherapy of cancerno. 7 (2022)
Cancer Researchno. 12_Supplement (2022): 4184-4184
Lakshmi Bollu,Prashant V. Bommi, Paige J. Monsen,Lijie Zhai,Kristen L. Lauing,April Bell,Miri Kim,Erik Ladomersky,Leonidas C. Platanias,Daniela E. Matei, Marcelo G. Bonini,Hidayatullah G. Munshi,
Social Science Research Network (2022)
Brain, Behavior, & Immunity - Health (2022): 100449
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn